Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

Taking the campaign against cancer into the cloud

Technology’s ability to accelerate the pace of innovation while reducing the cost is changing the dynamic of the struggle against cancer in myriad ways

- PMLiVE

Shaping tomorrow with strategic foresight in early commercialisation

Navigating the present while positioning therapies for long-term success

- PMLiVE

Brand strategy – reviewing what you’ve learnt

How to answer the most difficult questions in your strategy review

- PMLiVE

Merck gains rights to Hansoh’s preclinical GLP-1 candidate in deal worth $2bn

The company will evaluate the asset’s potential to provide cardiometabolic benefits beyond weight reduction

- PMLiVE

Amgen’s Blincyto granted MHRA approval for new acute lymphoblastic leukaemia indication

Approximately 300 new adult cases of the blood cancer are diagnosed in the UK every year

- PMLiVE

FDA approves Organon’s Vtama cream to treat atopic dermatitis in adults and children

More than 26 million people in the US are affected by the inflammatory skin disease

- PMLiVE

Rare vs common diseases: key differences in educational approaches

By Lisa Parker

- PMLiVE

Communicating AI in healthcare: a guide for effective strategy

By Sean Walker

- PMLiVE

Big hats, no cattle

You get what you like, not what you need

- PMLiVE

Pro bono work in pharma

Making a difference beyond the bottom line

Investors in People Platinum logo

Cuttsy+Cuttsy achieves Platinum accreditation from Investors in People

Cuttsy+Cuttsy is proud to have achieved a Platinum accreditation from Investors in People, placing them among the top 2% of organisations assessed globally.

Cuttsy + Cuttsy

- PMLiVE

AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition

The deal includes an IL23R inhibitor in preclinical development for psoriasis and inflammatory bowel disease

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links